From January 1990 to December 1993, all newly diagnosed patients with IBD from a well-defined area in South Eastern Norway were included in the Inflammatory Bowel South-Eastern Norway (IBSEN) study. The 20-year follow-up was conducted between 2011 and 2014. The Fatigue Questionnaire, the Short-Form 36 (SF-36), and the Hospital Anxiety and Depression Scale (HADS) were used to measure chronic fatigue, HRQOL, and anxiety and depression, respectively. Additionally, patients answered a questionnaire about CAM use.
Of 599 patients invited, 470 (ulcerative colitis 314, Crohn’s disease 156) participated in the study. Of these, 439 produced evaluable questionnaires. The use of CAM for their IBD was reported by 28% (n=122/439). CAM users were more likely to be women than men (60% vs 40%; P=0.02) and were younger than non-users (mean 49 vs 56 years; P<0.001). A significantly higher proportion of CAM users reported chronic fatigue (30% vs 20%; P=0.02). CAM users had significantly lower SF-36 scores in the following 3 dimensions: Vitality (51 vs 57; P≤0.01), Physical functioning (85 vs 89; P=0.04), and Social functioning (77 vs 84; P=0.01). There were no differences in anxiety and depression scores.
1. Opheim R, et al. ECCO 2019, P250.
Posted on
Previous Article
« Selective oral sphingosine 1-phosphate receptor modulator amiselimod Next Article
Vedolizumab superior to adalimumab in ulcerative colitis »
« Selective oral sphingosine 1-phosphate receptor modulator amiselimod Next Article
Vedolizumab superior to adalimumab in ulcerative colitis »
Table of Contents: ECCO 2019
Featured articles
Interview with Prof. Janneke van der Woude
New Compounds: Study Results
Short-term and Long-term Treatment Results
The right drug for the right patient
Vedolizumab superior to adalimumab in ulcerative colitis
Complementary and Alternative Medicine
Crohn’s disease exclusion diet + partial enteral nutrition in paediatric Crohn’s disease
Microbial composition and psychological wellbeing
Remission
Early remission of Crohn’s disease prevents progression
Proactive adalimumab trough measurements
Observational Studies
IBD risk of treatment with IL-17 antagonists
Basic and Preclinical Research
Immune cells and microbes: a happy marriage?
Genetics
Related Articles
May 9, 2019
Gene expression signature predicts non-response
May 9, 2019
Pathogenesis
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy